| Orders | Qty | Bid |
|---|---|---|
| 2 | 99 | 2339.4 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |

Emcure Pharmaceuticals Ltd has delivered 67.76% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,395.00 on 13 Nov 2026 and a 52-week low of ₹1,312.30 on 26 Nov 2025. It is currently trading at ₹2,339.40 as of 17 Nov 2026.
The all-time high (ATH) for Emcure Pharmaceuticals Ltd was ₹2,361.70, recorded on 13 Nov 2026. At the current price of ₹2,339.40, the stock is trading 0.94% below its all-time high. The all-time low recorded was ₹905.60 on 09 Apr 2025.
The intraday high for Emcure Pharmaceuticals Ltd on the NSE today (17 Nov 2026) was ₹2,397.50. This compares to the 52-week high of ₹2,395.00 recorded on 13 Nov 2026. Today's high was 0.10% above the 52-week high.
The intraday low for Emcure Pharmaceuticals Ltd on the NSE today was ₹2,335.00. The stock's 52-week low stands at ₹1,312.30, recorded on 26 Nov 2025. Today's low is 77.93% above the 52-week low, indicating the stock is trading well above its yearly lows.
As of 17 Nov 2026, the share price of Emcure Pharmaceuticals Ltd is ₹2,339.40 on the NSE and ₹2,332.85 on the BSE. The stock opened at ₹2,338.80, touched a high of ₹2,397.50 and a low of ₹2,335.00 during today's session.
Over the last 6 months, Emcure Pharmaceuticals Ltd has given a return of 38.70%. The stock was priced at ₹1,686.20 on 18 May 2026 and has Rise to ₹2,339.40 as of 17 Nov 2026, a change of ₹653.20 per share.
Emcure Pharmaceuticals Ltd has delivered a return of 24.81% over the last 3 months. The stock was trading at ₹1,873.90 on 17 Aug 2026 and is currently at ₹2,339.40 as of 17 Nov 2026, reflecting a Gain of ₹465.50 per share over this period.
Emcure Pharmaceuticals Ltd has delivered a N/A% absolute return over the past 5 years, equivalent to a CAGR of N/A% per annum. The stock was priced at ₹N/A in Nov 2021 and has fallen to ₹2,339.40 as of 17 Nov 2026. An investment of ₹1,00,000 in Emcure Pharmaceuticals Ltd five years ago would be worth ₹N/A today.
No,Emcure Pharmaceuticals Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of 6.60 per share between FY2022 and FY2026, with the most recent dividend of ₹3.60 per share for May 26, with an ex-dividend date of 04 Sep 2026. At the current market price of ₹2,339.40, the trailing dividend yield of Emcure Pharmaceuticals Ltd stands at 3.60%.
For Q2 FY27, Emcure Pharmaceuticals Ltd reported: Revenue (Net Sales): ₹16679.84 Cr - Up 14.96% year-on-year from ₹14509.31 Cr in Q1 FY27. Net Income (PAT): ₹2484.28 Cr - Up 24.15% year-on-year from ₹2001.08 Cr in Q1 FY27.